OTC Markets OTCPK - Delayed Quote USD

Innovent Biologics, Inc. (IVBXF)

5.94
0.00
(0.00%)
At close: May 13 at 4:00:00 PM EDT
All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
1,287,024
1,287,024
147,810
-1,918,804
-2,024,843
Investing Cash Flow
-1,165,411
-1,165,411
-998,662
-1,435,185
-2,698,148
Financing Cash Flow
-606,632
-606,632
2,587,257
2,892,082
5,003,361
End Cash Position
2,273,356
2,273,356
2,745,693
1,016,165
1,359,408
Capital Expenditure
-1,705,412
-1,705,412
-1,383,460
-1,381,730
-1,847,516
Issuance of Capital Stock
84,312
84,312
2,255,116
2,131,059
3,950,520
Issuance of Debt
515,571
515,571
1,335,549
1,080,172
1,463,083
Repayment of Debt
-1,220,049
-1,220,049
-917,050
-365,000
-255,000
Free Cash Flow
-418,388
-418,388
-1,235,650
-3,300,534
-3,872,359
12/31/2021 - 9/4/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers